Form 4 for BRTX BioRestorative Therapies, Inc.
Accepted 2022-07-15 00:00:00 ET · period of report 2022-07-06 · accession 0001567619-22-014051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-07-15 | 2022-07-06+ | BRTX | Broadrick Dale | 10% | P - Purchase | $3.01 | +1,200 | 298.4K | +0.4% | +$3,611 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-13 | P | A | 200 | $3.00 | 298,573 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-06 | P | A | 100 | $3.38 | 297,473 | D | — | — | |
| 3 | Common | Common Stock | 2022-07-12 | P | A | 900 | $2.97 | 298,373 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $2.95 to $2.9799 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. |